Grants and Contributions:
Title:
2425-HQ-000028
Agreement Number:
2425-HQ-000028
Agreement Value:
-$250,813.00
Agreement Date:
Dec 11, 2024 - Mar 31, 2027
Description:
To provide funding to willing jurisdictions to support improving access for patients with rare diseases to drugs for rare diseases, as well as improving and broadening rare disease treatments and services, to achieve better health outcomes.
Organization:
Health Canada
Expected Results:
Improved collaboration across provincial/territorial drug plans related to drugs for rare decisions decision-making.
Canadians with rare diseases have better access to screening and diagnostic services they need.
Location:
Toronto, Ontario, CA M7A 1N3
Reference Number:
271-2025-2026-Q1-00028
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Type:
Government
Additional Information:
Restatement of Award: The total award value of $535,136,325.00 reported in a previous quarter has been reduced by this Amendment.
Amendment Date
May 6, 2025
Recipient's Legal Name:
Government of Ontario - Ministry of Health and Long-Term Care
Program:
National Strategy for Drugs for Rare Diseases Program
Program Purpose:
Canadian Health Systems and Programs
Amendments: